Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: A joint ITCC and SIOPE brain tumor study

  1. Grill, J.
  2. Geoerger, B.
  3. Gesner, L.
  4. Perek, D.
  5. Leblond, P.
  6. Cañete, A.
  7. Aerts, I.
  8. Madero, L.
  9. De Toledo Codina, J.S.
  10. Verlooy, J.
  11. Estlin, E.
  12. Cisar, L.
  13. Breazna, A.
  14. Dorman, A.
  15. Bailey, S.
  16. Nicolin, G.
  17. Grundy, R.G.
  18. Hargrave, D.
Revue:
Neuro-Oncology

ISSN: 1522-8517,  1523-5866

Année de publication: 2013

Volumen: 15

Número: 9

Pages: 1236-1243

Type: Article

DOI: 10.1093/NEUONC/NOT097 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus